U.S. Virtual Visits Market (By Service Type: Cold & Flu management, Allergies, Urgent Care, Preventive Care, Chronic Care Management, Behavioural Health ; By Commercial Plan Type: Small Group, Self-Funded/ASO Group Plans, Medicaid, Medicare, By Age Group, By Gender)- Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1.Research Objective

1.2.Scope of the Study

1.3.Definition

Chapter 2.Research Methodology

2.1.Research Approach

2.2.Data Sources

2.3.Assumptions & Limitations

Chapter 3.Executive Summary

3.1.Market Snapshot

Chapter 4.Market Variables and Scope 

4.1.Introduction

4.2.Market Classification and Scope

4.3.Industry Value Chain Analysis

4.3.1.Raw Material Procurement Analysis 

4.3.2.Sales and Distribution Channel Analysis

4.3.3.Downstream Buyer Analysis

Chapter 5.COVID 19 Impact on U.S. Virtual Visits Market 

5.1.COVID-19 Landscape: U.S. Virtual Visits Industry Impact

5.2.COVID 19 - Impact Assessment for the Industry

5.3.COVID 19 Impact: Global Major Government Policy

5.4.Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6.Market Dynamics Analysis and Trends

6.1.Market Dynamics

6.1.1.Market Drivers

6.1.2.Market Restraints

6.1.3.Market Opportunities

6.2.Porter’s Five Forces Analysis

6.2.1.Bargaining power of suppliers

6.2.2.Bargaining power of buyers

6.2.3.Threat of substitute

6.2.4.Threat of new entrants

6.2.5.Degree of competition

Chapter 7.Competitive Landscape

7.1.1.Company Market Share/Positioning Analysis

7.1.2.Key Strategies Adopted by Players

7.1.3.Vendor Landscape

7.1.3.1.List of Suppliers

7.1.3.2.List of Buyers

Chapter 8.Global U.S. Virtual Visits Market, By Service Type

8.1.U.S.Virtual Visits Market, by Service Type Type, 2022-2030

8.1.1.Cold & Flu management

8.1.1.1.Market Revenue and Forecast (2017-2030)

8.1.2.Allergies

8.1.2.1.Market Revenue and Forecast (2017-2030)

8.1.3.Urgent Care

8.1.3.1.Market Revenue and Forecast (2017-2030)

8.1.4.Preventive Care

8.1.4.1.Market Revenue and Forecast (2017-2030)

8.1.5.Chronic Care Management

8.1.5.1.Market Revenue and Forecast (2017-2030)

8.1.6.Behavioral Health

8.1.6.1.Market Revenue and Forecast (2017-2030)

Chapter 9.Global U.S. Virtual Visits Market, By Age Group

9.1.U.S.Virtual Visits Market, by Age Group, 2022-2030

9.1.1.Age 18-34

9.1.1.1.Market Revenue and Forecast (2017-2030)

9.1.2.Age 35-49

9.1.2.1.Market Revenue and Forecast (2017-2030)

9.1.3.Age 50-64

9.1.3.1.Market Revenue and Forecast (2017-2030)

9.1.4.Age 65 and above

9.1.4.1.Market Revenue and Forecast (2017-2030)

Chapter 10.Global U.S. Virtual Visits Market, By Gender

10.1.U.S. Virtual Visits Market, by Gender, 2022-2030

10.1.1. Small Group

10.1.1.1.Market Revenue and Forecast (2017-2030)

10.1.2. Self-funded/ASO Group Plans

10.1.2.1.Market Revenue and Forecast (2017-2030)

10.1.3. Medicaid

10.1.3.1.Market Revenue and Forecast (2017-2030)

10.1.4. Medicare

10.1.4.1.Market Revenue and Forecast (2017-2030)

Chapter 11.Global U.S. Virtual Visits Market, By Gender

11.1.U.S. Virtual Visits Market, by Gender, 2022-2030

11.1.1. Male

11.1.1.1.Market Revenue and Forecast (2017-2030)

11.1.2. Female

11.1.2.1.Market Revenue and Forecast (2017-2030)

Chapter 12.U.S. Virtual Visits Market, Regional Estimates and Trend Forecast

12.1.U.S.

12.1.1.Market Revenue and Forecast, by Service Type (2017-2030)

12.1.2.Market Revenue and Forecast, by Gender (2017-2030)

Chapter 13.Company Profiles

13.1.American Well Corporation

13.1.1.Company Overview

13.1.2.Product Offerings

13.1.3.Financial Performance

13.1.4.Recent Initiatives

13.2.MDLive, Inc

13.2.1.Company Overview

13.2.2.Product Offerings

13.2.3.Financial Performance

13.2.4.Recent Initiatives

13.3.Doctor On Demand, Inc

13.3.1.Company Overview

13.3.2.Product Offerings

13.3.3.Financial Performance

13.3.4.Recent Initiatives

13.4.eVisit Telemedicine Solution

13.4.1.Company Overview

13.4.2.Product Offerings

13.4.3.Financial Performance

13.4.4.Recent Initiatives

13.5.Teladoc Health, Inc

13.5.1.Company Overview

13.5.2.Product Offerings

13.5.3.Financial Performance

13.5.4. Recent Initiatives

13.6.MeMD

13.6.1.Company Overview

13.6.2.Product Offerings

13.6.3.Financial Performance

13.6.4.Recent Initiatives

13.7.HealthTap, Inc

13.7.1.Company Overview

13.7.2.Product Offerings

13.7.3.Financial Performance

13.7.4.Recent Initiatives

13.8.Vidyo, Inc

13.8.1.Company Overview

13.8.2.Product Offerings

13.8.3.Financial Performance

13.8.4.Recent Initiatives

13.9.PlushCare, Inc

13.9.1.Company Overview

13.9.2.Product Offerings

13.9.3.Financial Performance

13.9.4.Recent Initiatives

13.10.Zipnosis

13.10.1.Company Overview

13.10.2.Product Offerings

13.10.3.Financial Performance

13.10.4.Recent Initiatives

Chapter 14.Research Methodology

14.1.Primary Research

14.2.Secondary Research

14.3.Assumptions

Chapter 15.Appendix

15.1.About Us

15.2.Glossary of Terms